BioXcel Therapeutics, Inc. (BTAIQ) Executive Compensation
BioXcel Therapeutics, Inc. (BTAIQ) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BTAIQ
CIK: 1720893
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerDevon Brady
Audit LocationStamford, Connecticut, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-30 | 2026-10-26 | FORM 8-K | 0001104659-26-120737 | View SEC Doc Filr Page |
| 8-K | 2026-09-01 | 2026-08-31 | FORM 8-K | 0001104659-26-104106 | View SEC Doc Filr Page |
| 8-K | 2026-08-28 | 2026-08-27 | FORM 8-K | 0001104659-26-102570 | View SEC Doc Filr Page |
| 8-K | 2026-08-25 | 2026-08-24 | FORM 8-K | 0001104659-26-100532 | View SEC Doc Filr Page |
| 8-K | 2026-08-24 | 2026-08-21 | FORM 8-K | 0001104659-26-099900 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-12 | OWNERSHIP DOCUMENT | 0001104659-26-097388 | View SEC Doc Filr Page |
| 3 | 2026-08-14 | 2026-08-12 | OWNERSHIP DOCUMENT | 0001104659-26-097387 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003557 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001104659-26-095965 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-10 | FORM 8-K | 0001104659-26-093710 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-07-31 | FORM 8-K | 0001104659-26-089436 | View SEC Doc Filr Page |
| 8-K | 2026-07-06 | 2026-07-06 | FORM 8-K | 0001104659-26-080501 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | OWNERSHIP DOCUMENT | 0001104659-26-075302 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | OWNERSHIP DOCUMENT | 0001104659-26-075301 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | OWNERSHIP DOCUMENT | 0001104659-26-075300 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | OWNERSHIP DOCUMENT | 0001104659-26-075298 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-04 | OWNERSHIP DOCUMENT | 0001104659-26-065841 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-04 | OWNERSHIP DOCUMENT | 0001104659-26-065839 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-04 | OWNERSHIP DOCUMENT | 0001104659-26-065838 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-04 | OWNERSHIP DOCUMENT | 0001104659-26-065836 | View SEC Doc Filr Page |
| 144 | 2026-05-20 | — | 144 Filing | 0001964306-26-000255 | View SEC Doc Filr Page |
| 144 | 2026-05-20 | — | 144 Filing | 0001964306-26-000254 | View SEC Doc Filr Page |
| 144 | 2026-05-20 | — | 144 Filing | 0001964306-26-000253 | View SEC Doc Filr Page |
| 144 | 2026-05-20 | — | 144 Filing | 0001964306-26-000252 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001172661-26-002135 | View SEC Doc Filr Page |